Detalhe da pesquisa
1.
Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors.
Br J Cancer
; 129(2): 266-274, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173365
2.
Metastatic Spiradenocarcinoma Managed With PD-1 Inhibition.
J Natl Compr Canc Netw
; : 1-3, 2022 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196645
3.
Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparin.
Cancer
; 127(6): 938-945, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216354
4.
Status of the Clinician Investigator in America: An Essential Healthcare Provider Driving Advances in Cancer Care.
J Natl Compr Canc Netw
; 19(2): 122-125, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545684
5.
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications.
BMC Cancer
; 20(1): 383, 2020 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32375706
6.
Inhibition of the chimeric DnaJ-PKAc enzyme by endogenous inhibitor proteins.
J Cell Biochem
; 120(8): 13783-13791, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30938854
7.
Novel organometallic chloroquine derivative inhibits tumor growth.
J Cell Biochem
; 119(7): 5921-5933, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29575007
8.
Breast cancer screening in patients with cancers other than breast.
Breast Cancer Res Treat
; 163(2): 343-348, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28265792
9.
When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients.
Oncology
; 92(1): 55-60, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27820931
10.
New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.
Am J Pathol
; 182(4): 1065-77, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23395095
11.
Impact of the Immediate Release of Clinical Information Rules on Health Care Delivery to Patients With Cancer.
JCO Oncol Pract
; 19(5): e706-e713, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780583
12.
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies.
Clin Cancer Res
; 29(13): 2435-2444, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227176
13.
A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms.
Clin Cancer Res
; 29(4): 731-741, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255391
14.
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1.
J Clin Oncol
; 40(12): 1291-1300, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260265
15.
Benchmarks for Academic Oncology Faculty.
JCO Oncol Pract
; 17(3): e440-e444, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32997608
16.
The Next Step in Your Career: Getting the Right Opportunity and the Right Contract.
Am Soc Clin Oncol Educ Book
; 40: 1-8, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32182140
17.
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study.
J Immunother Cancer
; 8(2)2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907924
18.
GPR30 predicts poor survival for ovarian cancer.
Gynecol Oncol
; 114(3): 465-71, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19501895
19.
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.
Gynecol Oncol
; 114(3): 480-5, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19560192
20.
Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers.
J Cancer Res Clin Oncol
; 145(10): 2541-2546, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31367835